Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
The branched-chain alpha-ketoacid dehydrogenase complex (BCKD) is an important regulator of the valine, leucine, and isoleucine catabolic pathways. Zusätzlich bieten wir Ihnen BCKDK Antikörper (76) und BCKDK Proteine (9) und viele weitere Produktgruppen zu diesem Protein an.
Showing 10 out of 22 products:
leucine supplementation increased the expression of enzymes (BCAT1 (zeige BCAT1 ELISA Kits), BCAT2 (zeige BCAT2 ELISA Kits) and BCKDK) that metabolize branched-chain amino acids.
Results suggest that targeting mitochondrial BCKD kinase (BDK) as a pharmacological approach to mitigate the branched-chain amino acids (BCAAs) accumulation in metabolic diseases and heart failure.
There is a relationship between plamsa CST (zeige GAL3ST1 ELISA Kits) and BCKDK in sepsis patients.
Results demonstrate that BCKDK mutations can result in neurobehavioral deficits in humans.
The branched-chain alpha-ketoacid dehydrogenase complex (BCKD) is an important regulator of the valine, leucine, and isoleucine catabolic pathways. The protein encoded by this gene is found in the mitochondrion, where it phosphorylates and inactivates BCKD. Several transcript variants encoding different isoforms have been found for this gene.
[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial
, branched chain ketoacid dehydrogenase kinase
, 3-methyl-2-oxobutanoate dehydrogenase [lipoamide] kinase, mitochondrial-like
, [3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial-like
, branched-chain alpha-ketoacid dehydrogenase kinase
, branched chain alpha-ketoacid dehydrogenase kinase
, branched chain keto acid dehydrogenase kinase